1/49
Looks like no tags are added yet.
Converting _______ is the rate-limiting (committed) step in cholesterol biosynthesis
HMG-CoA to Mevalonate
_______ is the major target for modern cholesterol-lowering drugs
HMG-CoA reductase
______ important cell membrane component precursor of steroid hormones, bile acids/salts
_______ was isolated from two Penicillium species (1976) & demonstrated potent, competitive inhibition of HMG-CoA reductase (its active form 10,000-fold greater affinity than substrate HMG-CoA)
Mevastatin
__________ was later discovered from two fungi (Monascus ruber & Aspergillus terreus) and found to be 2 fold more potent than mevastatin; only structural difference from mevastatin is 6' methyl group
Lovastatin
Mevastatin
Lovastatin
Statins inhibit the enzyme ________, reducing hepatic cholesterol synthesis.
HMG-CoA reductase
The active form of statins mimics the ________ intermediate of the HMG-CoA reduction reaction.
tetrahedral transition state
The essential pharmacophore of statins include
1) 3,5-dihydroxycarboxylate group
2) correct stereochemistry at C3 and C5
_________ and ___________ are prodrugs
Mevastatin and Lovastatin
Mevalonate
Mevastatin hydrogen bonds with HMG-CoA Reductase
A. Lactone form is inactive (prodrug) carboxylate is required for high binding affinity
B. mimics tetrahedral intermediate (at C-5)
C. 2-carbon linker optimal
D. Bicyclic ring tolerates structural modifications, can be relaced by other lipophilic rings. The size and shape of these ring systems are important to the overall activity of the compounds
E. Stereochemistry at C-3 and C-5 is critical (R, R)
The _________ form of statins is a prodrug, requiring hydrolysis to become active ____________
- ester (lactone)
- carboxylic acid
Lovastatin and simvastatin are derived from ________ and require activation by ________
- natural fungal products
- hydrolysis
Pravastatin is more ________ than lovastatin, enhancing hepatic selectivity and reducing side effects.
hydrophilic
Synthetic statins like atorvastatin and rosuvastatin replace the bicyclic system with ________ rings to simplify synthesis.
aromatic heterocyclic
Ezetimibe inhibits the ________ transporter in the intestinal brush border.
NPC1L1
The key structural feature of ezetimibe responsible for localization in the intestine is the ________ group.
phenolic hydroxyl
The fluorophenyl group in ezetimibe prevents ________ and ______
- oxidative metabolism
- prolongs its activity
Rosuvastatin's ________ enhances binding affinity through additional ________ interactions.
- sulfonamide group
- hydrogen bond
High LogP statins are more ________ and have ________ risk of myopathy.
- lipophilic
- greater
Hydrophilic statins rely on ________ transporters for hepatic uptake.
OATP1B1
Statin-associated myopathy is linked to depletion of ________ in the mevalonate pathway.
ubiquinone (CoQ10)
Ezetimibe reduces intestinal cholesterol absorption without affecting ________ or __________ absorption.
- triglyceride
- fat-soluble vitamin
Statins lower plasma LDL by _______ on hepatocytes.
increasing expression of LDL receptors
Rosuvastatin binds to Arg590 via its ________
fluorobenzene ring system.
Rosuvastatin introduced a _________, enhancing hydrogen bonding (Arg590) and reducing LogP for higher hepatic selectivity.
sulfonamide and fluorophenyl group
Pitavastatin incorporated a _________, maintaining potency with favorable pharmacokinetics
quinoline system
Rosuvastatin
_______ has extra contacts with HMGR
The ________ in ezetimibe is essential for inhibitory activity.
β-lactam (azetidinone) ring
Bempedoic acid inhibits the enzyme ________ upstream of HMG-CoA reductase.
ATP-citrate lyase
________ is much more hydrophilic than lovastatin and simvastatin
Pravastatin
Atorvastatin
C
C) 5-alcohol center
A
D) bicyclic ring system
The _________ is essential for inhibitory activity; _________ are prodrugs
3,5-dihydroxycarboxylate
lactone compounds
The absolute stereochemistry of _________ must be the same as found in lovastatin
3- and 5 hydroxyl groups
For statins, a _________ distance between C5 and the ring system is optimal
two carbon (C6-C7)
A _________ can either increase or decrease activity, depending on the ring system
double bond between C6 and C7
The _________ that anchors the CoA binding pocket can tolerate modifications
ring system
A. Help to localize the compound in the intestine
B. Block undesirable metabolism
New drug won't be able to Hydrogen bond to the S565 (sulfonamide group) or do the strong H-bond with Arg590 in the enzyme. ∴ LESS POTENT NEW DRUG
A. β-Lactam (azetidinone) ring: essential for inhibitory activity
B. Fluorophenyl group: blocks oxidative metabolism, prolonging action
C. Phenolic hydroxyl group: localizes drug within intestinal mucosa and undergoes glucuronidation to active metabolite.
A. Glucuronidation
D. Oxidation (C=O)